Ruffer’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$110K Sell
19,246
-403,712
-95% -$3.74M 0.01% 181
2026
Q2
$3.54M Buy
+422,958
New +$3.86M 0.13% 119

Other funds holding ADMA

Ruffer's ADMA Position: Q3 2026 in Review

Ruffer reduced its ADMA Biologics (ADMA) stake by 95% in Q3 2026, selling an estimated $3.74M and leaving 19,246 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #181.

Ruffer first reported a position in ADMA in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.54M in Q2 2026. 262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Ruffer held 19,246 shares of ADMA Biologics worth $110K as of Q3 2026.
  • Ruffer sold 403,712 ADMA Biologics shares in Q3 2026, an estimated $3.74M.
  • ADMA Biologics made up 0.01% of Ruffer's portfolio in Q3 2026, its #181 holding.
  • Ruffer first reported a position in ADMA Biologics in Q2 2026 and has held it in 2 quarters since.
  • Ruffer's ADMA Biologics position peaked at $3.54M in Q2 2026.
  • 262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.